companydata.dkCystotech ApS: Financial statements 2023
CVR: 42773565
Cystotech ApS (CVR 42773565) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,612,282 and a net result of DKK -1,597,349. Equity amounted to DKK 7,603,436. The solvency ratio was 55.8%. The company had 4 employees in the financial year.
- Gross Profit
- 1,612,282 kr.
- Profit/Loss
- -1,597,349 kr.
- Equity
- 7,603,436 kr.
- Total Assets
- 13,620,670 kr.
- Employees
- 4
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 21, 2023, Lars Christian Lund has joined the board of directors of Cystotech ApS.
As of September 1, 2023, CH MEDINVEST ApS is registered as an owner of Cystotech ApS with an ownership share of 5%.
As of September 1, 2023, Den Midtjyske Iværksætterfond is registered as an owner of Cystotech ApS with an ownership share of 5%.
As of September 1, 2023, h6capital ApS is registered as an owner of Cystotech ApS with an ownership share of 5%.
As of September 1, 2023, Skovly-Munk Holding ApS is registered as an owner of Cystotech ApS with an ownership share of 10%.
As of September 1, 2023, Cloudbeam Holding ApS is registered as an owner of Cystotech ApS with an ownership share of 10%.
Cystotech ApS has published its interim report for the period October 20, 2021 – December 31, 2022.
About Cystotech ApS
Cystotech ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Hansen and Anna Munk Nielsen. The company's owners include CH MEDINVEST ApS, Den Midtjyske Iværksætterfond and h6capital ApS. In 2025, the company reported a gross profit of DKK 1,528,137 and a net result of DKK -4,382,149 compared with DKK -3,454,057 the year before. Equity amounted to DKK 24,841,030.